Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone bioavailability: implications for DST research.

M T Lowy, H Y Meltzer

    Biological Psychiatry
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.

    Journal of neurochemistry·1996
    Same author

    Genetic variation of 5-HT2A receptor and response to clozapine.

    Lancet (London, England)·1995
    Same author

    Association study between the dopamine D4 receptor gene and schizophrenia.

    American journal of medical genetics·1995
    Same author

    Neuropeptide Y in frontal cortex is not altered in major depression.

    Journal of neurochemistry·1995
    Same author

    Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men.

    Biological psychiatry·1995
    Same author

    Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia.

    Archives of general psychiatry·1995
    Same journal

    Impact of Transcranial Direct Current Stimulation-Induced Electric Fields on Slowing Cognitive Decline in Older Adults With Mild Cognitive Impairment or Remitted Major Depressive Disorder: An Analysis of the PACt-MD Randomized Clinical Trial.

    Biological psychiatry·2026
    Same journal

    Remembering Jon-Kar Zubieta, M.D., Ph.D.

    Biological psychiatry·2026
    Same journal

    Kappa opioid receptor availability in borderline personality disorder: An in-vivo investigation with [<sup>11</sup>C]EKAP PET imaging.

    Biological psychiatry·2026
    Same journal

    From Satiety to Substance Use: Neural Mechanisms of GLP-1 Signaling in Appetite and Reward.

    Biological psychiatry·2026
    Same journal

    Distinct and Shared Molecular Mechanisms Underlie Morphological-Functional Overcoupling and Undercoupling in Major Depressive Disorder.

    Biological psychiatry·2026
    Same journal

    Dynamic Brain States With Cannabis Intoxication: Beyond "More Is Better" in Interpreting Brain Connectivity.

    Biological psychiatry·2026
    See all related articles

    Dexamethasone bioavailability impacts Dexamethasone Suppression Test (DST) results in psychiatric patients. Measuring both dexamethasone and cortisol levels is crucial for accurate DST interpretation in neuroendocrine research.

    Area of Science:

    • Neuroendocrinology
    • Pharmacokinetics
    • Psychiatry

    Background:

    • Dexamethasone bioavailability is critical for Dexamethasone Suppression Test (DST) interpretation.
    • Variability in serum dexamethasone levels affects DST outcomes.
    • Drug interactions can alter dexamethasone's effectiveness.

    Purpose of the Study:

    • To review dexamethasone bioavailability in relation to DST use in neuroendocrine research.
    • To highlight factors influencing dexamethasone levels and DST results.
    • To emphasize the need for simultaneous dexamethasone and cortisol measurements.

    Main Methods:

    • Review of existing literature on dexamethasone bioavailability and DST.
    • Discussion of analytical methods for dexamethasone quantification (RIA, HPLC, GC-MS).

    Related Experiment Videos

  • Examination of dexamethasone metabolism and elimination pathways.

    • Main Results:

    • Hepatic metabolism is the primary route for dexamethasone elimination.
    • Significant variability in serum dexamethasone levels exists across patient populations.
    • Concurrent drug use can modify serum dexamethasone levels.

    Conclusions:

    • Simultaneous measurement of serum dexamethasone and cortisol is essential for accurate DST evaluation.
    • Understanding dexamethasone bioavailability can resolve inconsistencies in DST research.
    • Further research into dexamethasone metabolism is warranted.